BENSON HILL INC (BHIL) Fundamental Analysis & Valuation

NASDAQ:BHIL • US0824902029

0.249 USD
-0.17 (-41.19%)
At close: Mar 26, 2025
0.17 USD
-0.08 (-31.73%)
After Hours: 3/26/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BHIL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, BHIL scores 2 out of 10 in our fundamental rating. BHIL was compared to 88 industry peers in the Food Products industry. BHIL has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BHIL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. BHIL Profitability Analysis

1.1 Basic Checks

  • BHIL had negative earnings in the past year.
  • BHIL had a negative operating cash flow in the past year.
  • In the past 5 years BHIL always reported negative net income.
  • In the past 5 years BHIL always reported negative operating cash flow.
BHIL Yearly Net Income VS EBIT VS OCF VS FCFBHIL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M

1.2 Ratios

  • BHIL has a Return On Assets of -73.99%. This is amonst the worse of the industry: BHIL underperforms 87.91% of its industry peers.
  • BHIL has a Return On Equity of -379.14%. This is amonst the worse of the industry: BHIL underperforms 87.91% of its industry peers.
Industry RankSector Rank
ROA -73.99%
ROE -379.14%
ROIC N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A
BHIL Yearly ROA, ROE, ROICBHIL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

  • With a Gross Margin value of 5.33%, BHIL is not doing good in the industry: 81.32% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BHIL has declined.
  • The Profit Margin and Operating Margin are not available for BHIL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%
BHIL Yearly Profit, Operating, Gross MarginsBHIL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. BHIL Health Analysis

2.1 Basic Checks

  • BHIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BHIL has been reduced compared to 1 year ago.
  • The debt/assets ratio for BHIL is higher compared to a year ago.
BHIL Yearly Shares OutstandingBHIL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
BHIL Yearly Total Debt VS Total AssetsBHIL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

  • BHIL has an Altman-Z score of -6.14. This is a bad value and indicates that BHIL is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BHIL (-6.14) is worse than 84.62% of its industry peers.
  • BHIL has a Debt/Equity ratio of 3.12. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 3.12, BHIL is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF N/A
Altman-Z -6.14
ROIC/WACCN/A
WACC9.33%
BHIL Yearly LT Debt VS Equity VS FCFBHIL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 2.21 indicates that BHIL has no problem at all paying its short term obligations.
  • BHIL has a better Current ratio (2.21) than 67.03% of its industry peers.
  • A Quick Ratio of 1.74 indicates that BHIL should not have too much problems paying its short term obligations.
  • BHIL has a Quick ratio of 1.74. This is amongst the best in the industry. BHIL outperforms 80.22% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.74
BHIL Yearly Current Assets VS Current LiabilitesBHIL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BHIL Growth Analysis

3.1 Past

  • BHIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.20%, which is quite good.
  • Looking at the last year, BHIL shows a very negative growth in Revenue. The Revenue has decreased by -49.19% in the last year.
  • BHIL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 156.06% yearly.
EPS 1Y (TTM)14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
Revenue 1Y (TTM)-49.19%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Sales Q2Q%-69.84%

3.2 Future

  • Based on estimates for the next years, BHIL will show a very strong growth in Earnings Per Share. The EPS will grow by 23.04% on average per year.
  • Based on estimates for the next years, BHIL will show a very negative growth in Revenue. The Revenue will decrease by -33.44% on average per year.
EPS Next Y40.84%
EPS Next 2Y34.39%
EPS Next 3Y23.04%
EPS Next 5YN/A
Revenue Next Year-71.85%
Revenue Next 2Y-52.14%
Revenue Next 3Y-33.44%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BHIL Yearly Revenue VS EstimatesBHIL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
BHIL Yearly EPS VS EstimatesBHIL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

Find the best growth stocksShow best growing peers

1

4. BHIL Valuation Analysis

4.1 Price/Earnings Ratio

  • BHIL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BHIL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHIL Price Earnings VS Forward Price EarningsBHIL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHIL Per share dataBHIL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 30

4.3 Compensation for Growth

  • BHIL's earnings are expected to grow with 23.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.39%
EPS Next 3Y23.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BHIL Dividend Analysis

5.1 Amount

  • No dividends for BHIL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BHIL Fundamentals: All Metrics, Ratios and Statistics

BENSON HILL INC

NASDAQ:BHIL (3/26/2025, 8:00:02 PM)

After market: 0.17 -0.08 (-31.73%)

0.249

-0.17 (-41.19%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-25
Earnings (Next)05-07
Inst Owners17.2%
Inst Owner Change0%
Ins Owners8.84%
Ins Owner Change0%
Market Cap1.52M
Revenue(TTM)205.59M
Net Income(TTM)-101.77M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.82%
Min EPS beat(2)-67.13%
Max EPS beat(2)-30.51%
EPS beat(4)1
Avg EPS beat(4)-40.73%
Min EPS beat(4)-67.24%
Max EPS beat(4)1.96%
EPS beat(8)3
Avg EPS beat(8)-18.22%
EPS beat(12)6
Avg EPS beat(12)-8.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)10.88%
Min Revenue beat(2)-14.5%
Max Revenue beat(2)36.26%
Revenue beat(4)2
Avg Revenue beat(4)6.8%
Min Revenue beat(4)-25.47%
Max Revenue beat(4)36.26%
Revenue beat(8)5
Avg Revenue beat(8)7.9%
Revenue beat(12)7
Avg Revenue beat(12)-2.44%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.07
EV/EBITDA N/A
EPS(TTM)-21.02
EYN/A
EPS(NY)-4.75
Fwd EYN/A
FCF(TTM)-6.91
FCFYN/A
OCF(TTM)-6.55
OCFYN/A
SpS33.65
BVpS4.39
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.99%
ROE -379.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.33%
FCFM N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 3.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.42%
Cap/Sales 1.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 1.74
Altman-Z -6.14
F-Score3
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)124.08%
Cap/Depr(5y)136.84%
Cap/Sales(3y)13.82%
Cap/Sales(5y)13.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.43%
EPS Next Y40.84%
EPS Next 2Y34.39%
EPS Next 3Y23.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-49.19%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Sales Q2Q%-69.84%
Revenue Next Year-71.85%
Revenue Next 2Y-52.14%
Revenue Next 3Y-33.44%
Revenue Next 5YN/A
EBIT growth 1Y11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.41%
EBIT Next 3Y24.07%
EBIT Next 5YN/A
FCF growth 1Y66.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.14%
OCF growth 3YN/A
OCF growth 5YN/A

BENSON HILL INC / BHIL FAQ

Can you provide the ChartMill fundamental rating for BENSON HILL INC?

ChartMill assigns a fundamental rating of 2 / 10 to BHIL.


What is the valuation status for BHIL stock?

ChartMill assigns a valuation rating of 1 / 10 to BENSON HILL INC (BHIL). This can be considered as Overvalued.


Can you provide the profitability details for BENSON HILL INC?

BENSON HILL INC (BHIL) has a profitability rating of 0 / 10.


Can you provide the financial health for BHIL stock?

The financial health rating of BENSON HILL INC (BHIL) is 3 / 10.


Can you provide the expected EPS growth for BHIL stock?

The Earnings per Share (EPS) of BENSON HILL INC (BHIL) is expected to grow by 40.84% in the next year.